Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SpartanNash Reports 3.7% Increase in Q1 Net Sales

SpartanNash, a food solutions company, has reported its financial results for the first quarter of fiscal 2025. The highlights from the report include a 3.7% increase in net sales to $2.91 billion. This growth was driven by a 19.6% increase in the retail segment's net sales, amounting to $947.2 million, primarily due to incremental sales from acquired stores. Additionally, retail comparable store sales saw a 1.6% increase.

However, net earnings decreased to $2.1 million or $0.06 per diluted share, compared to $13.0 million or $0.37 per diluted share in the same period last year. Adjusted EPS also decreased to $0.35 from $0.53.

On a positive note, adjusted EBITDA increased to $76.9 million from $74.9 million, driven by improved wholesale margins, lower restructuring and asset impairment charges, and decreased corporate administrative costs.

It's worth noting that cash generated from operating activities decreased to $25.8 million from $36.5 million, and capital expenditures and IT capital decreased to $34.6 million from $44.1 million. SpartanNash also returned $8.0 million to shareholders through dividends.

Looking ahead, SpartanNash reaffirmed its previous fiscal 2025 guidance provided on February 12, 2025. The company expects total net sales to be between $9.8 billion and $10.0 billion, adjusted EBITDA to be between $263 million and $278 million, and adjusted EPS to be between $1.60 and $1.85. The guidance incorporates the investments and benefits from the company’s long-term strategic initiatives, including all transformational programs and tuck-in acquisitions.

Following these announcements, the company's shares moved 9.03%, and are now trading at a price of $21.2399. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS